Market Research Logo

Global Gastroparesis Drugs Market 2017-2021

Global Gastroparesis Drugs Market 2017-2021

About Gastroparesis Drugs

Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract. Normally, the vagus nerve controls the stomach muscles, which are responsible for the movement of food in the stomach. These muscles contract to break up the food and lead to its movement through the gastrointestinal tract. Gastroparesis can be caused due to the damage of vagus nerve by illness or injury. The disease does not have complete remission; however, proper medications along with the changes in diet can provide relief.

Technavio’s analysts forecast the global gastroparesis drugs market to grow at a CAGR of 3.54% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global gastroparesis drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Gastroparesis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Cadila Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Valeant
Other prominent vendors
  • Evoke Pharma
  • Teva Pharmaceutical Industries
  • Theravance Biopharma
Market driver
  • Rising cases of diabetes fueling the prevalence of diabetic gastroparesis.
  • For a full, detailed list, view our report
Market challenge
  • Difficulty in diagnosis is hampering the medication process.
  • For a full, detailed list, view our report
Market trend
  • Introduction of novel ways for the treatment of gastroparesis symptoms.
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Gastroparesis Drugs Market 2017-2021

Technavio recognizes the following companies as the key players in the global gastroparesis drugs market: Cadila Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, and Valeant.

Other Prominent Vendors in the market are: Evoke Pharma, Teva Pharmaceutical Industries, and Theravance Biopharma.

Commenting on the report, an analyst from Technavio’s team said: “One trend in market is fast track approvals and acquisitions to change the phase of the market. High unmet needs in the treatment of gastroparesis have led the fast track approvals of certain drugs. For example, in 2016, Theravance Biopharma received the US FDA fast track designation for velusetrag for idiopathic and diabetic gastroparesis. At present, the drug is in Phase II clinical stage. The fast track approval by the US FDA is done to facilitate the need to treat serious conditions associated with gastroparesis.”

According to the report, one driver in market is rising gastric surgeries fueling the prevalence rate of post-surgical gastroparesis. Post-surgical gastroparesis is the third most common type of the gastroparesis after idiopathic and diabetic gastroparesis. Gastric surgeries include surgeries that are done to digestive parts of the bodies such as the esophagus, duodenum, and stomach. During the gastric surgery, there is a high chance that the vagus nerves get injured. Injury to these nerves is the major cause of gastroparesis. Some of the common types of gastric surgeries are gastric bypass surgeries and bariatric surgeries. Rising obesity is a major reason for these surgeries. As one of the major aims of these surgeries is weight loss. Vagus nerve damage is one of the major complications associated with gastric bypass. Sleeve gastrectomy has also seen to alter the gut-brain communication.

Further, the report states that one challenges in market is weak pipeline for gastroparesis. The weak pipeline of gastroparesis is a huge challenge for the gastroparesis drugs market. At present Metozolv ODT (metoclopramide hydrochloride) is the only US FDA-approved drug used for the treatment of diabetic gastroparesis. The situation is even worse for idiopathic gastroparesis, which does not have any US FDA-approved drug for its treatment. Even though there are very limited options available for the treatment of gastroparesis, the pipeline is quite thin. Most of the drugs currently in the pipeline focus on diabetic gastroparesis, which suggests that idiopathic gastroparesis is still an un-addressed segment of the market. The R&D process for idiopathic gastroparesis becomes even more difficult because of lack of knowledge regarding the actual cause of the disease. Current drug development for gastroparesis lags behind many other pharmaceutical developments. This restricts the growth of gastroparesis market. Also, termination of clinical trials is expected to hamper the market growth. For instance, GlaxoSmithKline and Adolor received a letter of approval for a New Drug Application (NDA) for alvimopan, a new drug for the treatment of IBS, slow transit constipation, and gastroparesis. However, it was later suspended due to long-term safety concerns.

Companies Mentioned

Cadila Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Valeant, Evoke Pharma, Teva Pharmaceutical Industries, and Theravance Biopharma.

  • Executive ummary
  • Scope of the eport
  • Research ethodology
  • Introduction
    • Key market highlights
  • Disease Overview
    • Table Causes of gastroparesis
    • Table Major complications associated with gastroparesis
    • Table Diagnosis and treatment of gastroparesis
  • Market landscape
    • Market overview
      • Table Global gastroparesis drugs market snapshot
      • Table Global gastroparesis drug market 2016-2021 ($ millions)
      • Table Opportunity analysis in global gastroparesis drugs market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline summary based on vendors
    • Table Key clinical trials
  • Market segmentation by disease type
    • Table Segmentation of global gastroparesis drugs market by disease type 2016
    • Table Global gastroparesis drugs market share by disease type 2016 (%)
    • Table Market snapshot: Global gastroparesis drugs market 2016-2021
    • Diabetic gastroparesis
      • Table Function of vagus nerves in digestive system
      • Table Global diabetic gastroparesis drugs market 2016-2021 ($ millions)
    • Idiopathic gastroparesis
      • Table Global idiopathic gastroparesis drugs market 2016-2021 ($ millions)
    • Others
      • Table Other causes of gastroparesis
      • Table Global gastroparesis drugs market by other causes 2016-2021 ($ millions)
  • Market segmentation by drug class
    • Table Segmentation of global gastroparesis drug market by drug class
    • Table Market analysis of gastroparesis drug class
    • Prokinetic agents
    • Antiemetic agents
    • Botulinum toxin injection
  • Geographical segmentation
    • Table Global gastroparesis drugs market based on geography 2016 and 2021
    • Table Global gastroparesis drugs market revenue by geography 2016-2021 ($ millions)
    • Gastroparesis drugs market in Americas
      • Table Market scenario in Americas
      • Table Gastroparesis drugs market in the Americas 2016-2021 ($ millions)
      • Table Top American countries with diabetic population range (millions)
    • Gastroparesis drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Gastroparesis drugs market in EMEA 2016-2021 ($ millions)
    • Gastroparesis drugs market in APAC
      • Table Market scenario in APAC
      • Table Top Asian countries with diabetic population range (millions)
      • Table Gastroparesis drugs market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table New cases of diabetes by 2040
      • Table Possible treatments for gastroparesis.
    • Market challenges
      • Table Alternate treatment options for gastroparesis
      • Table Factors affecting the diagnosis of gastroparesis
  • Market trends
    • Fast track approvals and acquisitions to change the phase of the market
    • Introduction of novel ways for the treatment of gastroparesis symptoms
  • Vendor landscape
    • Competitive scenario
      • Table Strategic success factors of companies in global gastroparesis drug market
      • Table Competitive structure analysis of global gastroparesis market
    • Cadila Pharmaceuticals
      • Table Cadila Pharmaceuticals: Key highlights
      • Table Cadila Pharmaceuticals: Strength assessment
      • Table Cadila Pharmaceuticals: Strategy assessment
      • Table Cadila Pharmaceuticals: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Johnson & Johnson
      • Table Johnson & Johnson: Key highlights
      • Table Johnson & Johnson: Strength assessment
      • Table Johnson & Johnson: Strategy assessment
      • Table Johnson & Johnson: Opportunity assessment
    • Valeant
      • Table Valeant: Key highlights
      • Table Valeant: Strength assessment
      • Table Valeant: Strategy assessment
      • Table Valeant: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report